You are here

StampPump: a Postage-Stamp Sized Autonomous Glycemic Control Mechanism for Patients Suffering Glycemic Abnormalities as a Result of Critical Illnesses

Award Information
Agency: Department of Defense
Branch: Defense Advanced Research Projects Agency
Contract: W911NF19C0029
Agency Tracking Number: D18C-004-0033
Amount: $224,124.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: ST18C-004
Solicitation Number: 18.C
Timeline
Solicitation Year: 2018
Award Year: 2019
Award Start Date (Proposal Award Date): 2019-03-25
Award End Date (Contract End Date): 2020-01-24
Small Business Information
39 Karen Road
Waban, MA 02468
United States
DUNS: 080493730
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Mervyn (Dod) Michael
 Chief Scientific Officer
 (317) 258-0963
 dod@thermalin.com
Business Contact
 Susan Andreottola
Phone: (617) 938-3510
Email: susan@thermalin.com
Research Institution
 Indiana University School of Medicine
 Michael A. Weiss, M.D., Ph.D. Michael A. Weiss, M.D., Ph.D.
 
340 W 10th St #6200
Indianapolis, IN 46202
United States

 (317) 274-1717
 Nonprofit college or university
Abstract

StampPump is a postage-stamp-sized (27x27x6 mm), fully-self-contained, closed-loop insulin patch pump system that is filled at the factory with enough insulin to treat a person with T1- or trauma-induced hyperglycemia for a full week. The device is shelf stable for at least 90 days and so is compatible with critical-care or forward deployment use. We propose to augment this system with the ability to control delivery of counter-regulatory medications -- either glucagon or dextrose -- so that it can automatically mitigate hyperglycemia while reducing the risk of hypoglycemia. The augmented system would be designed for simple deployment by critical care nurses or even field medics.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government